# PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

Study · id `cardio:ct-nct03970538` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03970538](<https://clinicaltrials.gov/study/NCT03970538>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03970538

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 105 participants.

## Technical summary

Registry record NCT03970538. Allocation not applicable; no masking; primary purpose treatment. Start 2019-12-06 (actual); primary completion 2022-09-09 (actual). Results posted on 2024-02-28.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 105 participants (enrolled count; ClinicalTrials.gov record NCT03970538, source copy `cardio:ctgov-nct03970538-2024-02-28`, retrieved 2026-10-31)
- Started: 2019-12-06 (actual) (ClinicalTrials.gov record NCT03970538, source copy `cardio:ctgov-nct03970538-2024-02-28`, retrieved 2026-10-31)
- Primary completion: 2022-09-09 (actual) (ClinicalTrials.gov record NCT03970538, source copy `cardio:ctgov-nct03970538-2024-02-28`, retrieved 2026-10-31)
- Completion: 2025-02-28 (anticipated) (ClinicalTrials.gov record NCT03970538, source copy `cardio:ctgov-nct03970538-2024-02-28`, retrieved 2026-10-31)
- Results first posted: 2024-02-28 (ClinicalTrials.gov record NCT03970538, source copy `cardio:ctgov-nct03970538-2024-02-28`, retrieved 2026-10-31)
- Countries: United States; Puerto Rico (ClinicalTrials.gov record NCT03970538, source copy `cardio:ctgov-nct03970538-2024-02-28`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03970538-2024-02-28`, retrieved 2026-10-31)

## The registry's words

- Brief title: PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
- Acronym: PROMISE
- Condition: Critical Limb Ischemia
- Condition: Critical Lower Limb Ischemia
- Condition: Peripheral Artery Disease
- Condition: Peripheral Arterial Disease
- Condition: Chronic Limb-Threatening Ischemia
- Condition: Arterial Occlusive Diseases
- Condition: Arterial Occlusion
- Condition: Arterial Disease
- Condition: Peripheral Artery Occlusion
- Condition: Peripheral Vascular Disease
- Condition: Peripheral Ischemia
- Condition: Vascular Diseases
- Intervention (Device): LimFlow System
- Lead sponsor: LimFlow, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)

## Provenance

Content hash: 0e44474daa5d4a78f7c88689b2edbc51a79b056db3535bb4f5b3747ffe8edcfe
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
